MCID: MCR011
MIFTS: 41

Microinvasive Gastric Cancer

Categories: Cancer diseases, Gastrointestinal diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Microinvasive Gastric Cancer

MalaCards integrated aliases for Microinvasive Gastric Cancer:

Name: Microinvasive Gastric Cancer 11 14
Early Gastric Cancer 11 53 14 71
Surface Gastric Cancer 11

Classifications:



External Ids:

Disease Ontology 11 DOID:10541
NCIt 49 C27131
SNOMED-CT 68 276809004
UMLS 71 C0349530

Summaries for Microinvasive Gastric Cancer

MalaCards based summary: Microinvasive Gastric Cancer, also known as early gastric cancer, is related to adenocarcinoma and gastric ulcer, and has symptoms including abdominal pain and dyspepsia. An important gene associated with Microinvasive Gastric Cancer is TDRG1 (Testis Development Related 1), and among its related pathways/superpathways is E-cadherin signaling in keratinocytes. The drugs Pantoprazole and Acetylsalicylic acid have been mentioned in the context of this disorder. Affiliated tissues include lymph node, bone marrow and colon, and related phenotypes are neoplasm and digestive/alimentary

Related Diseases for Microinvasive Gastric Cancer

Diseases related to Microinvasive Gastric Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 511)
# Related Disease Score Top Affiliating Genes
1 adenocarcinoma 31.4 VEGFC MLH1 CEACAM5 CDX2 CDH1
2 gastric ulcer 31.3 S100A8 GAST ATP12A
3 diffuse gastric cancer 31.3 S100A8 PDPN MLH1 CTNNA1 CDH1
4 adenoma 31.2 MUC6 MLH1 CDX2 CDH1
5 gastric adenocarcinoma 31.2 S100A8 MLH1 GAST CEACAM5 CDX2 CDH1
6 gastritis 31.2 S100A8 MUC6 MIR196A1 GAST CDX2 CDH1
7 tubular adenocarcinoma 31.2 MUC6 CTNNA1 CEACAM5 CDX2 CDH1
8 signet ring cell adenocarcinoma 31.2 PDPN MUC6 MLH1 CEACAM5 CDX2 CDH1
9 peptic esophagitis 31.1 S100A8 GAST CDX2 ATP4A ATP12A
10 appendix adenocarcinoma 31.1 CEACAM5 CDX2
11 peptic ulcer disease 31.0 S100A8 GAST ATP4A ATP12A
12 postgastrectomy syndrome 30.9 ATP4A ATP12A
13 pernicious anemia 30.9 GAST ATP4A ATP12A
14 atrophic gastritis 30.8 S100A8 MIR20A MIR196A1 GAST CDX2 ATP4A
15 mucinous adenocarcinoma 30.8 MUC6 MLH1 CEACAM5 CDX2
16 colonic benign neoplasm 30.8 MLH1 GAST CEACAM5 CDX2 CDH1
17 krukenberg carcinoma 30.7 CEACAM5 CDX2
18 lymphoma, mucosa-associated lymphoid type 30.7 S100A8 GAST ATP4A ATP12A
19 linitis plastica 30.7 CTNNA1 CEACAM5 CDX2 CDH1
20 vitamin b12 deficiency 30.7 GAST ATP4A ATP12A
21 gastric cancer 30.6 XIST VEGFC TDRG1 S100A8 PSG2 PDPN
22 bile reflux 30.6 S100A8 GAST CDX2 ATP4A ATP12A
23 cholecystitis 30.5 S100A8 MUC6 CDH1
24 hernia, hiatus 30.5 GAST ATP4A ATP12A
25 gastric lymphoma 30.5 S100A8 ATP4A ATP12A
26 cardia cancer 30.5 S100A8 GAST ATP4A ATP12A
27 gastroesophageal reflux 30.5 S100A8 GAST CDX2 ATP4A ATP12A
28 gastric antral vascular ectasia 30.4 GAST ATP4A ATP12A
29 marginal zone b-cell lymphoma 30.4 S100A8 ATP4A ATP12A
30 adenoid squamous cell carcinoma 30.3 CEACAM5 CDH1
31 transverse colon cancer 30.3 MLH1 CEACAM5
32 ascending colon cancer 30.3 MLH1 CEACAM5 CDX2
33 adenocarcinoma in situ 30.3 PDPN MUC6 CEACAM5 CDX2
34 colorectal adenoma 30.2 MLH1 CEACAM5 CDH1
35 gastrointestinal system disease 30.2 S100A8 MIR20A MIR196A1 MIR15B GAST
36 splenic artery aneurysm 30.2 ATP4A ATP12A
37 squamous cell carcinoma 30.2 VEGFC PDPN CEACAM5 CDH1 BCYRN1
38 cholangiocarcinoma 30.2 VEGFC CTNNA1 CEACAM5 CDX2 CDH1
39 autoimmune gastritis 30.2 S100A8 MUC6 GAST ATP4A ATP12A
40 lymphocytic gastritis 30.2 GAST ATP4A ATP12A
41 mediastinitis 30.2 ATP4A ATP12A
42 gastric neuroendocrine neoplasm 30.2 GAST ATP4A ATP12A
43 duodenogastric reflux 30.2 GAST ATP4A ATP12A
44 choledocholithiasis 30.2 CEACAM5 ATP4A ATP12A
45 rectal benign neoplasm 30.1 MLH1 MIR20A CEACAM5 CDX2
46 pseudomyxoma peritonei 30.1 MUC6 CEACAM5 CDX2 CDH1
47 gallbladder disease 30.1 PDPN MIR196A1 CEACAM5 CDH1
48 nutritional deficiency disease 30.1 GAST ATP4A ATP12A
49 villous adenoma 30.1 MUC6 MLH1 CEACAM5 CDX2
50 intestinal obstruction 30.0 CEACAM5 CDX2 ATP4A ATP12A

Graphical network of the top 20 diseases related to Microinvasive Gastric Cancer:



Diseases related to Microinvasive Gastric Cancer

Symptoms & Phenotypes for Microinvasive Gastric Cancer

UMLS symptoms related to Microinvasive Gastric Cancer:


abdominal pain; dyspepsia

MGI Mouse Phenotypes related to Microinvasive Gastric Cancer:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.5 ATP4A CDH1 CDX2 CEACAM5 CTNNA1 GAST
2 digestive/alimentary MP:0005381 9.23 ATP12A ATP4A CDH1 CDX2 CEACAM5 GAST

Drugs & Therapeutics for Microinvasive Gastric Cancer

Drugs for Microinvasive Gastric Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 89)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Pantoprazole Approved Phase 4 102625-70-7, 138786-67-1 4679
2
Acetylsalicylic acid Approved, Vet_approved Phase 4 50-78-2 2244
3
Clopidogrel Approved Phase 4 120202-66-6, 113665-84-2 60606
4
Rabeprazole Approved, Investigational Phase 4 117976-89-3, 117976-90-6 5029
5 Anti-Inflammatory Agents Phase 4
6 Analgesics, Non-Narcotic Phase 4
7 Antirheumatic Agents Phase 4
8 Fibrinolytic Agents Phase 4
9 Antipyretics Phase 4
10 Purinergic P2Y Receptor Antagonists Phase 4
11 Cyclooxygenase Inhibitors Phase 4
12 Platelet Aggregation Inhibitors Phase 4
13 Anti-Inflammatory Agents, Non-Steroidal Phase 4
14 Proton Pump Inhibitors Phase 4
15 Gastrointestinal Agents Phase 4
16 Anti-Ulcer Agents Phase 4
17 Antacids Phase 4
18
Racepinephrine Approved, Vet_approved Phase 3 51-43-4, 329-65-7 838 5816
19
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613
20
Esomeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6, 119141-88-7 9568614 4594
21
Clarithromycin Approved Phase 3 81103-11-9 84029
22 Anesthetics Phase 3
23 Hemostatics Phase 3
24 Adrenergic alpha-Agonists Phase 3
25 Adrenergic Agonists Phase 3
26 Adrenergic Agents Phase 3
27 Epinephryl borate Phase 3
28 Bronchodilator Agents Phase 3
29 Adrenergic beta-Agonists Phase 3
30 Anti-Asthmatic Agents Phase 3
31 Vasoconstrictor Agents Phase 3
32 Respiratory System Agents Phase 3
33 Mydriatics Phase 3
34 Sympathomimetics Phase 3
35 Anti-Bacterial Agents Phase 3
36 Anti-Infective Agents Phase 3
37 Antibiotics, Antitubercular Phase 3
38 Cytochrome P-450 Enzyme Inhibitors Phase 3
39 Cytochrome P-450 CYP3A Inhibitors Phase 3
40 Analgesics Phase 2
41
Dexlansoprazole Approved, Investigational 138530-94-6 9578005
42
Dexamethasone acetate Approved, Investigational, Vet_approved 1177-87-3 3680
43
Lansoprazole Approved, Investigational 103577-45-3 3883
44
Dexamethasone Approved, Investigational, Vet_approved 50-02-2 3003 5743
45
Sucralfate Approved 54182-58-0
46
Methylene blue Approved, Investigational 61-73-4 6099
47
Dexmedetomidine Approved, Experimental, Vet_approved 86347-14-0, 113775-47-6 68602 5311068
48
Remifentanil Approved 132875-61-7 60815
49
Propofol Approved, Investigational, Vet_approved 2078-54-8 4943
50
Lidocaine Approved, Vet_approved 137-58-6 3676

Interventional clinical trials:

(show top 50) (show all 76)
# Name Status NCT ID Phase Drugs
1 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel
2 Effects of Ilaprazole 20mg on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone Endoscopic Submucosal Dissection(ESD) for Gastric Adenoma or Early Gastric Cancer. Completed NCT02638584 Phase 4 Ilaprazole;Rabeprazole
3 Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases: A Prospective Self-controlled Comparative Multicenter Trial Completed NCT02219529 Phase 3
4 Prospective Randomized Trial of Laparoscopy-assisted Distal Gastrectomy (LADG) Versus Open Distal Gastrectomy (ODG) in Patients With Early Gastric Cancer (EGC) Completed NCT00546468 Phase 3
5 Multicenter Randomized Controlled Trial of Gastric Endoscopic Submucosal Dissection With or Without Epineprhine Added Solution Recruiting NCT04032119 Phase 3 Epinephrine
6 Effect of Helicobacter Pylori Eradication on Glandular Atrophy and Metachronous Cancer in Patients Undergoing Endoscopic Mucosal Resection for Gastric Cancer Active, not recruiting NCT02407119 Phase 3 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin;Placebo, Omeprazole or Rabeprazole, Clarithromycin
7 Non-exposure Simple Suturing Endoscopic Full-Thickness Resection (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) Unknown status NCT03837301 Phase 2
8 A Phase II Study of Robot Assisted Distal Gastrectomy With Nodal Dissection for Clinical Stage Ia Gastric Cancer Unknown status NCT01504997 Phase 2
9 The Effect of Uncut Roux-en-Y Gastrojejunostomy on Quality of Life After Laparoscopic Distal Gastrectomy for Early Gastric Cancer Patients Unknown status NCT02644148 Phase 2
10 A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Laparoscopic-assisted Gastrectomy in Early Gastric Cancer Patients Completed NCT02522598 Phase 2 VVZ-149 injections;Placebo
11 The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer Completed NCT02347956 Phase 1, Phase 2
12 Prospective Clinical Trials on Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy With Lymph Node Dissection for Early Gastric Cancer Not yet recruiting NCT04973475 Phase 2 Indocyanine Green
13 Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection Unknown status NCT02090062
14 Comparison of Diagnostic Performance of Medical Monitor and Medical Augmented Reality Glasses in Endoscopy: Observation Study Unknown status NCT04083573
15 Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection Unknown status NCT02037399 intravenous dexamethasone;intravenous normal saline
16 Development and Validation of a Predictive Model for Early Gastric Cancerous Lesions Under Endoscopic Observation Unknown status NCT02968069
17 Prospective Study of Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion and Endoscopic Tumor Size Estimation for Early Gastric Cancer Unknown status NCT01832246
18 The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer and Evaluate the Invasive Depth of Tumors Unknown status NCT02710838
19 Gastric Cancer Sentinel Lymph Node Sampling: Refining Patient Selection for Organ Sparing Resection of Early Gastric Cancer in a North American Context Unknown status NCT03049345 Radioactive Tracers;Methylene Blue 20 MG/ML
20 Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection:a New Therapy for Early Gastric Cancer Unknown status NCT02325999 Early Phase 1
21 Pilot Study of Non-exposure Simple Suturing EFTR (NESS-EFTR) With Sentinel Lymph Node Navigation for Early Gastric Cancer (Senorita3-pilot) Unknown status NCT03216174
22 A Prospective Randomized Study of Linked Color Imaging and Conventional White Light Imaging in Gastroscopy for the Detection of Gastric Cancer Precursors Unknown status NCT03990025
23 Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer Unknown status NCT01659632
24 Verifying the Specificity of the Method Combining Nomogram and Sentinel Lymph Node in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients: a Prospective, Single Arm, Observational Study Unknown status NCT03632746
25 Magnifying Endoscopy With Narrow Band Imaging Versus Endoscopic Ultrasonography for Prediction of Tumor Invasion Depth in Early Gastric Cancer: A Prospective Comparative Study Unknown status NCT03546257
26 An Educational Intervention, the First Step of the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer:Prospective Study With Historical Control Unknown status NCT02385578
27 Application of Linked Color Imaging(LCI) in Diagnosis of Early Gastric Cancer(EGC): a Multicenter,Prospective, Randomized Controlled Study Unknown status NCT03661671
28 Long-term Follow-up After Endoscopic Submucosal Dissection for Early Gastric Cancer Unknown status NCT01132469
29 Evaluation of the Diagnostic Ability of White Light Endoscopy and Magnifying Endoscopy With Optical Enhancement System in Early Gastric Cancer and Intraepithelial Neoplasia: a Prospective Randomized Controlled Trial Unknown status NCT04411589
30 Laparoscopy-assisted Pylorus-vagus Nerve Preserving Gastrectomy in the Treatment of Early Gastric Cancer: Clinical Outcomes of a Randomised Controlled Trial Unknown status NCT02936193
31 Screening and Triage Test for Early Detection of Gastric Cancer Unknown status NCT01774266
32 Setting the Shortest Examination Time of Gastroscopy to Improve the Detection Rate of Upper Gastrointestinal Tumors: a Multi-center, Prospective, Controlled Study Completed NCT04602299
33 Necessity Assessment of Magnifying Endoscopy With Narrow Band Imaging Targeted Biopsy Compared With Endoscopic Forceps Biopsy From White Light Endoscopy Completed NCT02738294
34 A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil Completed NCT01920113 Dexmedetomidine - remifentanil group;Propofol - remifentanil group
35 Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring Completed NCT01921283 no- BIS sensor attachment
36 Postoperative Pain and Quality of Life After Single-incision Distal Gastrectomy Versus Totally Laparoscopic Distal Gastrectomy for Early Gastric Cancer - a Randomized Controlled Trial Completed NCT01938326
37 The Effect of Proton Pump Inhibitor and Polaprezinc Combination Therapy for Healing of Endoscopic Submucosal Dissection-induced Ulcer Completed NCT02243618 Polaprezinc;Rebamipide
38 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Than Endoscopic Gastric Atrophy Classification and OLGIM Stage: A Prospective Study Completed NCT02562976
39 The Accuracy of Probe-based Confocal Endomicroscopy Versus Conventional Biopsies for the Diagnosis of Superficial Gastric Neoplasias Completed NCT01688687
40 Effect of Gastrectomy and Anastomosis on Chronic Metabolic Disease Such as Diabetes and Hypertension in Early Gastric Cancer Patients Completed NCT01643811
41 Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection Completed NCT02504164 midazolam 0.02mg/kg;No premedication
42 Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection Against Laparoscopic Assisted Gastrectomy for Treatment of Early Gastric Cancer Completed NCT03136354
43 Nexium Capsules Specific Clinical Experience Investigation Concerning Helicobacter Pylori Eradication Completed NCT01435525
44 Absorption of Anti-tuberculosis Drugs and Its Effect to Treatment Response in Gastrectomized Patients Completed NCT01364324 standard first line anti-TB drugs
45 Performance of Endoscopic Submucosal Dissection According to the Sedation Method Completed NCT01806753
46 Quality Control Study for Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy and Stomach Preserving Surgery in Early Gastric Cancer Completed NCT01544413
47 Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer Completed NCT01813994 Arm1: Statin;Arm2: Placebo
48 Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy and Stomach Preserving Surgery in Early Gastric Cancer Completed NCT01804998
49 Long-term Outcomes of Endoscopic Submucosal Dissection Versus Gastrectomy for Early Gastric Cancer Completed NCT02216110
50 Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection Completed NCT02189226

Search NIH Clinical Center for Microinvasive Gastric Cancer

Genetic Tests for Microinvasive Gastric Cancer

Anatomical Context for Microinvasive Gastric Cancer

Organs/tissues related to Microinvasive Gastric Cancer:

MalaCards : Lymph Node, Bone Marrow, Colon, Liver, Bone, Skeletal Muscle, Spleen

Publications for Microinvasive Gastric Cancer

Articles related to Microinvasive Gastric Cancer:

(show top 50) (show all 5323)
# Title Authors PMID Year
1
Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. 53 62
19117016 2009
2
Histopathological predictor for regional lymph node metastasis in gastric cancer. 53 62
19104832 2009
3
Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines. 53 62
19940363 2009
4
Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein. 53 62
18648315 2009
5
[Expression of epithelial cadherin in early gastric cancer and its correlation to lymph node micrometastasis and clinicopathologic features]. 53 62
17672949 2007
6
[Clinicopathological and biological features of micrometastasis in early gastric cancers]. 53 62
17571311 2007
7
[Effect of surgical manipulation on the dissemination of cancer cells into peripheral blood in patients with gastric cancer and its risk factor analysis]. 53 62
17520381 2007
8
Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. 53 62
17261130 2007
9
Detection of lymph node micrometastasis in pN0 early gastric cancer: efficacy of duplex RT-PCR with MUC2 and TFF1 in mucosal cancer. 53 62
16820924 2006
10
Histologic and serum risk markers for noncardia early gastric cancer. 53 62
15688378 2005
11
Syndecan-1 and E-cadherin expression in differentiated type of early gastric cancer. 53 62
15902740 2005
12
Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma. 53 62
15513361 2004
13
[Expression of beta-catenin and E-cadherin in early gastric cancer: correlation with clinicopathologic parameters]. 53 62
14978364 2004
14
[Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer]. 53 62
12776596 2003
15
Relationship between gastric disease and deletion of cag pathogenicity island genes of Helicobacter pylori in gastric juice. 53 62
12645789 2003
16
Evaluation of carcinoembryonic antigen mRNA in living, necrotic, and apoptotic gastric cancer cells by reverse transcriptase-polymerase chain reaction. 53 62
14605956 2003
17
The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. 53 62
12552462 2003
18
Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. 53 62
11856141 2002
19
BGP expression in gastric biopsies may predict the development of new lesions after local treatment for early gastric cancer. 53 62
12378338 2002
20
BGP expression in gastric epithelium and early gastric cancer. 53 62
12378336 2002
21
Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. 53 62
11706763 2001
22
[A case of radiologically negative small-cell lung carcinoma successfully detected early by whole-body FDG-PET]. 53 62
11296386 2001
23
Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. 53 62
11684825 2001
24
Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. 53 62
11113859 2000
25
Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients. 53 62
10642939 1999
26
Loss of E-cadherin expression in early gastric cancer. 53 62
10231415 1999
27
[The expression of thymidylate synthase and thymidine phosphorylase in the early-stage of gastric cancer]. 53 62
10065095 1999
28
Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. 53 62
10461060 1999
29
The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer. 53 62
9681606 1998
30
High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. 53 62
9175208 1997
31
Single-cell mutation analysis of tumors from stained histologic slides. 53 62
8973475 1996
32
Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas. 53 62
8641546 1996
33
Red blood cell distribution width as a novel marker for predicting bleeding after endoscopic resection for early gastric cancer. 62
36247311 2023
34
Usefulness of third-generation narrow band imaging and texture and color enhancement imaging in improving visibility of superficial early gastric cancer: A study using color difference. 62
36439990 2023
35
Mixed Histologic Type is a Risk Factor for Lymph Node Metastasis in Submucosal Invasive Early Gastric Cancer. 62
36306586 2023
36
Endoscopic Submucosal Dissection in the Stomach and Duodenum: Techniques, Indications, and Outcomes. 62
36375887 2023
37
Gastric Emptying is Accelerated in Patients With Gastric Tube Reconstruction Following Laparoscopic Proximal Gastrectomy. 62
36223321 2022
38
Artificial intelligence for diagnosing gastric lesions under white-light endoscopy. 62
35879572 2022
39
The impact of sarcopenia on short- and long-term outcomes of endoscopic submucosal dissection for early gastric cancer. 62
36129538 2022
40
Higher prevalence of LAP+ (Latency TGFβ-Associated Peptide) T cells at the tissue level in patients with early gastric cancer. 62
36332356 2022
41
Automatic captioning of early gastric cancer using magnification endoscopy with narrow-band imaging. 62
35917877 2022
42
A case of early gastric cancer resembling a subepithelial lesion diagnosed by endoscopic ultrasound-guided fine needle aspiration. 62
36198987 2022
43
Diagnostic accuracy of linked colour imaging versus white light imaging for early gastric cancers: a prospective, multicentre, randomized controlled trial study. 62
36411585 2022
44
A rare helicobacter pylori infection-negative early gastric cancer in a young man with primary hypertrophic osteoarthropathy. 62
35081636 2022
45
Linked color imaging-based endoscopic grading of gastric intestinal metaplasia and histological gastritis staging in the assessment of gastric cancer risk. 62
35701150 2022
46
Gel immersion endoscopic mucosal resection for early gastric cancer near the pyloric ring. 62
35120390 2022
47
Applicability of endoscopic submucosal dissection for patients with early gastric cancer beyond the expanded indication for endoscopic submucosal dissection. 62
35546209 2022
48
Clinical significance of the number of retrieved lymph nodes in early gastric cancer with submucosal invasion. 62
36401371 2022
49
Linked color imaging improves identification of early gastric cancer lesions by expert and non-expert endoscopists. 62
35508665 2022
50
Epstein-Barr virus detection in endoscopic submucosal dissection-proven early gastric cancer with mixed-type histology. 62
36421012 2022

Variations for Microinvasive Gastric Cancer

Expression for Microinvasive Gastric Cancer

Search GEO for disease gene expression data for Microinvasive Gastric Cancer.

Pathways for Microinvasive Gastric Cancer

Pathways related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 9.88 CTNNA1 CDH1

GO Terms for Microinvasive Gastric Cancer

Cellular components related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 flotillin complex GO:0016600 8.92 CTNNA1 CDH1

Biological processes related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular response to indole-3-methanol GO:0071681 8.92 CTNNA1 CDH1

Molecular functions related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 P-type sodium:potassium-exchanging transporter activity GO:0005391 9.46 ATP4A ATP12A
2 P-type potassium transmembrane transporter activity GO:0008556 8.96 ATP4A ATP12A
3 P-type potassium:proton transporter activity GO:0008900 8.92 ATP4A ATP12A

Sources for Microinvasive Gastric Cancer

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....